Moderna (MRNA) Acquisitions (2023)

Moderna (MRNA) reported Acquisitions of $85.0 million for Q1 2023.

Moderna (MRNA) Acquisitions (2023) Analysis & Trends

Moderna (MRNA) has 1 years of Acquisitions data on file, last reported at $85.0 million in Q1 2023.

  • Acquisitions for Q1 2023 came in at $85.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $85.0 million (changed N/A YoY), and the FY2023 annual result was $85.0 million, changed N/A from the prior year.
  • Acquisitions held at $85.0 million in Q1 2023 per MRNA's latest filing.
  • Over five years, Acquisitions peaked at $85.0 million in Q1 2023 and troughed at $85.0 million in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Moderna 25.27 Bn 20.06 Bn -566.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 85.00 Mn